IDEXX LABORATORIES NASDAQ: IDXX
Background of IDEXX Laboratories
- IDEXX Laboratories Inc is an American multinational corporation involved with the development, manufacture, and distribution of products and services for veterinary, livestock and poultry, water testing, and dairy markets.
- IDEXX Laboratories Inc is headquartered in Westbrook, Maine, and EMEA in Hoofddorp, Netherlands.
- IDEXX Laboratories Inc offers products to customers in more than 175 countries around the world.
- There are three main segments of the company: Companion Animal Group, Water segment, and Livestock, Poultry and Dairy (LPD).
- IDEXX Laboratories Inc also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses.
- IDEXX Laboratories Inc has a rich history that dates to 1983 when IDEXX Laboratories Inc was founded by David Shaw with five employees in Portland, Maine.
- Within a few years, the company became a leader in immunoassay kits, including the now industry-renowned SNAP family of tests that detect diseases in cats, dogs, and other animals.
- By 1991, IDEXX Laboratories Inc had become a publicly traded company and over the next decades grew to evolve as a world leader in veterinary diagnostic instrument development and manufacture, reference laboratory services and dairy and water testing.
- IDEXX Laboratories Inc is committed to assisting veterinary practices to thrive by supporting change and continuous improvement through advanced information-sharing technology, education, and knowledge.
- IDEXX Laboratories Inc accomplishes these goals through proprietary practice management systems and education channels such as the IDEXX Learning Center.
- In 2008, IDEXX Laboratories Inc surpassed the $1 billion revenue mark just 25 years after start-up.
- In 2011, IDEXX Laboratories Inc introduced pethealthnetwork.com, a trusted resource where veterinarians can connect with pet owners seeking to learn more about keeping pets healthy and happy.
- In 2011, IDEXX Laboratories Inc invested $76 million in research and development, most of which occurs at the Westbrook headquarters, resulting in products that are exported to more than 100 countries worldwide.
- In 2012 IDEXX Laboratories Inc began construction on Westbrook’s first LEED® certified building, a new administrative facility that will expand its world campus.
- In keeping with IDEXX’s commitment to fostering employee well-being, the company promoted both mental and physical health through a significant employee health and wellness centre that opened in 2013; the introduction of a new collaborative workspace design that is being adopted as a best practice by other highly innovative companies; and a focus on serving healthy meals in the multiple on-site cafeterias.
- IDEXX Laboratories Inc oversees a high-value product portfolio which enhance the health and well-being of all pets, people, and livestock.
- IDEXX Laboratories Inc’s products and services include major brands and other services are centred on diagnostic imaging and veterinary practice management software systems, including the flagship program Cornerstone, as well as DVMax, Animana and several legacy practice management software systems.
- The Water segment provides products to measure microbiological parameters in water.
- IDEXX Laboratories Inc’s Livestock and Poultry Diagnostics division provides products to detect diseases in livestock and poultry.
- Today, IDEXX Laboratories Inc is truly one of the most valuable healthcare companies in the world with a market capitalization of US$ 58.21 billion recorded in July 2025.
- In 2025 the total staff compliment for IDEXX Laboratories Inc was more than 9 300.
- IDEXX Laboratories Inc’s executive leadership team consists of: Lawrence D. Kingsley – Independent Chairman of the Board; Jonathan Mazelsky – President, Chief Executive Officer, Director; Brian P. McKeon – Chief Financial Officer, Executive Vice President, Treasurer; Giovani Twigge – Chief Human Resource Officer, Senior Vice President; and Tina Hunt – Executive Vice President, General Manager, Point of Care Diagnostics and Worldwide Operations.
IDEXX Laboratories Shares Growth Driver
- IDEXX Laboratories Inc accomplishes its mission through intelligent innovation that continues to produce a steady stream of new products and services, aimed to enhance the health and well-being of all pets, people and livestock.
- IDEXX Laboratories Inc takes sustainability seriously through an approach that aligns with business objectives, ensures social and stakeholder responsibility, and demonstrates environmental stewardship.
- Strong sales at the core Companion Animal Group (CAG) and Livestock, Poultry and Dairy (LPD) arms are driving the top line for IDEXX Laboratories Inc. The company is also registering sturdy gains in CAG Diagnostics’ recurring revenues, supported by sustained strong global trends in pet healthcare.
- IDEXX Laboratories Inc stock has been a coronavirus winner, climbing over 90% since January 2025 and soundly beating the S&P500.
- IDEXX Laboratories Inc is going to launch a new test called ProCyte One, a new best-in-class blood analysing machine, which could be a blockbuster hit within the veterinary community.
- As such, the company’s innovative and competitive portfolio has allowed it to defy the market trends surrounding the coronavirus pandemic, with performance and shares still attractive after a tumultuous 2025.
IDEXX Laboratories Investor Tip
- IDEXX Laboratories Inc trades its shares on the NASDAQ Stock Market (NASDAQ) under the stock symbol IDXX. IDEXX Laboratories Inc forms part of the NASDAQ-100.
- An analysis on IDEXX Laboratories Inc’s market performance and income statement indicates Revenue (ttm) of 2.86 billion, Revenue Per Share (ttm) 33.48, Quarterly Revenue Growth (yoy) 24.20%, Gross Profit (ttm) 1.57 billion, EBITDA 895.67 million, Net Income Avi to Common (ttm) 674.21 million and Diluted EPS (ttm) 7.77.
- IDEXX Laboratories Inc shares have charted a solid trajectory in recent times, appreciating 95.3% over the past year, ahead of 22% growth of its industry and 40% surge of the S&P 500 composite.
- Over the past five years, IDEXX Laboratories Inc registered earnings growth of 24.6%, way ahead of the industry’s 3.7% rise and the S&P 500’s 2.8% increase.
- IDEXX Laboratories Inc’s long-term expected growth rate of 19.6% also exceeds the industry’s 16.8% growth projection and the S&P 500’s 10.9% expectation.
- IDEXX Laboratories Inc markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers.
- IDEXX Laboratories Inc delivered a stable performance despite the economic impact which resulted from the global coronavirus pandemic. This stable performance can be largely owed to the company’s diverse portfolio, as well as its strong medical supplies sector which witnessed growing demand as hospitals geared up to combat the virus.
- With sound financials and significant, consistent, and continuous growth forecasted for the remainder of 2025, shareholders who buy or sell shares can expect lucrative dividends and returns.
- Overall, the company’s a stable performance has resulted in healthy dividends and a good share price for investors who choose to purchase shares today, securing a decent buy-in in 2025 and in the future.
- For more information regarding the company’s forecast, the buy or sell of shares and the live price chart, visit the company’s online Investor Relations page.
- Data from this analysis should be weighed against forecasted performance during this pandemic, but for now, prices on shares and in turn dividends remain unaffected, which provides shareholders with assurance that they will have a strong buy-in on NASDAQ.
Sector
Healthcare
Industry
Diagnostics & Research
Sub industry
Livestock and veterinary services and products
Latest News
IDEXX Laboratories: How to buy IDEXX Laboratories Shares Online
Here are the steps you need to follow to buy IDEXX Laboratories Inc shares with utmost confidence:
- Navigate to the AvATrade website and select ‘Register’.
- Complete the registration form with the required information and submit documentation to verify your proof of Identity along with your proof of address.
- As soon as your account application has been reviewed and approved, you can select your trading platform from AvATrade’s website, or by visiting the MetaTrader 4 or MetaTrader 5 websites respectively to start download.
- Once you have downloaded the trading platform of your choice, you can use your AvATrade live account details to log into your AvATrade account on the trading platform.
- From the Market Watch screen on both MetaTrader 4 and MetaTrader 5, you can select ‘IDEXX Laboratories Inc’ or ‘IDXX’ to buy/purchase shares.
- Alternatively, you can make use of AvATrade’s online Web Trader or the AvATradeGo mobile application.
Trading CFDs and Stocks with AvATrade provides traders with the following benefits:
- Leverage of up to 1:20.
- Being able to trade stocks on the NYSE, NASDAQ, FTSE, and various others.
- Indices, stocks, and commodities can all be traded form a single screen.
- Client support is presented live in a multitude of languages.
- Traders have exclusive access to a variety of educational tools.
- Trades can be executed across multiple platforms.
More shares that can be purchased through AvATrade, can be viewed here.
FAQ
Can I buy IDEXX Laboratories Inc shares in South Africa?
Yes, you can.
How to buy IDEXX Laboratories Inc shares?
By simply opening a free account with SA Shares, or by clicking the “Buy this Share” button to get started.
What is the current share price?
By clicking on the link provided above, you can view the real-time IDEXX Laboratories Inc share price on the platform.
Is IDEXX Laboratories Inc a good share to buy?
Yes, it is. Despite the growing concerns surrounding Covid-19, IDEXX Laboratories Inc is continuing manufacturing, sales and delivery of its products and it is forecasted to be one of the very few automotive companies to make a significant rebound post-Covid-19.
Can I buy IDEXX Laboratories Inc CFD through SA Shares?
Yes, you can.
Top 4 Brokers
